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Abstract: While reducing racial/ethnic and socioeconomic disparities in cancer mortality 
has been identified as a national goal, current policies are unlikely to achieve it. In order 
to advance the development of policies for the primary prevention of cancer and cancer 
disparities, we propose that the practices of the tobacco, alcohol, and food industries be 
considered as modifiable social determinants of health. We review evidence that the practices 
of these industries in product design, marketing, retail distribution, and pricing contribute 
to cancer risk behavior, incidence, and disparities, then examine public health strategies 
designed to reduce health-damaging practices of these industries and encourage healthier 
alternatives. We conclude with recommendations for research, practice, and policy that 
could contribute to the development of less carcinogenic corporate practices. 
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The United States has made eliminating racial/ethnic and other disparities in health a national goal1 and the National Cancer Institute and the American Cancer 
Society have committed to reducing disparities in cancer incidence and mortality.2,3 To 
date, however, most cancer research has focused on secondary prevention and treat-
ment. The evidence base for developing policies for the primary prevention of cancer 
is limited, making it more difficult to achieve significant progress towards the goal of 
reducing cancer disparities. Research shows that tobacco and alcohol use and diet play 
central roles in the etiology of many types of cancer,3–5 yet modifying behavior one 
person at a time has proven to be only modestly effective in reducing the incidence 
of new cancers. Compelling evidence suggests that the behavior of organizations such 
as governments and corporations also plays a central role in explaining the incidence 
and distribution of cancer.4,5 
More specifically, in this commentary we assess whether corporate practices, such 
as advertising, product design, pricing, retailing, and political lobbying for market 
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advantage, might contribute to disparities in the incidence of cancer among different 
racial/ethnic and socioeconomic groups. In particular, we examine whether the prac-
tices of the tobacco, alcohol, and food industries might contribute to the incidence 
and distribution of lung, breast, cervical, liver, colon/rectum, prostate, pancreatic, and 
other cancers, which account for about half of U.S. cancer incidence and mortality and 
a significant portion of cancer disparities.2,3 
In the course of the paper, we consider corporate policies as social determinants of 
disparities in cancer incidence and mortality between racial/ethnic groups and between 
populations with higher and lower socioeconomic status. We identify and describe the 
pathways by which specific corporate practices contribute to disparities in cancer and 
discuss the societal costs that may be associated with these practices and their influ-
ence on population health. We conclude with a discussion of public health strategies 
that can be used to change corporate practices that increase access to and distribution 
of carcinogenic products. Our ultimate goal is to suggest research, policy, and practice 
directions that can reduce cancer incidence and disparities by changing the practices 
of the tobacco, alcohol, and food industries.
Disparities in Cancer morbidity and mortality in the U.S.
Despite recent progress in reducing the death rate from cancer, the U.S. still reports 
increasing cancer incidence in several major types of cancer and sharp racial/ethnic and 
socioeconomic disparities in incidence or mortality from lung, breast, cervical, liver, 
stomach, colon and other cancers.3,6 Several organizations, including the Institute of 
Medicine,7 the National Cancer Institute, the U.S. Department of Health and Human 
Services (DHHS),1 and the American Cancer Society have made reducing or eliminat-
ing these disparities a major priority. 
As shown in Table 1, the incidence and mortality rates for most major cancers related 
to tobacco use, alcohol, and diet are consistently higher for African Americans than 
for Whites. African American males have higher incidence and mortality rates than 
Whites for six of seven sites shown below, and African American females have higher 
incidence rates for four and higher mortality rates for seven of eight sites. Together, 
these types of cancer account for more than half of all estimated new cases and more 
than 60% of the estimated deaths in the U.S. in 2005. Latinos, Asian Americans, and 
Native Americans also have higher incidence and mortality rates from liver cancer 
than Whites have.3,6 
Socioeconomic status also contributes to disparities in cancer. In 1991, Dr. Samuel 
Broder, then Director of the National Cancer Institute (NCI), observed that “poverty 
is a carcinogen.”8 An NCI study comparing U.S. cancer mortality by county showed 
that poorer counties had higher mortality rates for colorectal and prostate cancer and 
that overall cancer mortality for men living in poorer counties was 13% higher than 
for men in better-off counties.9,10 Risk factors for cancer also vary by race/ethnicity and 
socioeconomic status.7,11,12 Those with incomes less than twice the poverty level are 
much more likely to be smokers than those with higher incomes;13 obesity levels are 
higher among African Americans and Latinos and lower-income groups than among 
their respective counterparts.14 While the proportion of alcohol users increases with 
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income, poor, Black and Hispanic problem drinkers are less likely to get help for these 
problems.15,16 
Many of the differences in cancer incidence have been attributed to differences in 
health behaviors such as tobacco, alcohol use, and diet. However, public health inter-
ventions designed to change individual behavior or modify environments at the com-
munity level have proven to be only modestly successful and have not served to reduce 
cancer disparities. By accelerating changes in behavior, it may be possible to achieve 
greater reduction in cancer;17 policy change may be a more effective acceleration tool 
than individual-level interventions. In fact, Link and Phelan18 and others have argued 
that strategies that rely only on providing individuals with health information can 
exacerbate rather than reduce disparities by providing greater benefits to those with 
more education and resources. The growing concentration of tobacco-related illnesses 
among low-income and African American and Latino U.S. populations illustrates this 
phenomenon.13,19 
table 1.
U.S. CanCeR InCIDenCe anD moRtaLIty, SeLeCteD SIteS
   Black/white Black/white evidence of 
   incidence mortality causal factors 
 total   ratios ratios related to
 estimated estimated     tobacco (t),  
 new cases deaths  Fe-  Fe- alcohol (a), 
type of cancer 2005 2005 male male male male  or food (F)
Prostate 232,090  30,350 1.6 — 2.4 — F(?)
Lung and
 bronchus 172,570 163,510 1.5 1.0 1.4 1.0 T
Colon and  
 rectum 145,290  56,290 1.1 1.2 1.4 1.4 T,A,F
Urinary system  101,880  26,590 .5 .8 .7 1.3 T
Pancreas  32,180  31,800 1.4 1.5 1.3 1.4 T,F
Oral cavity
 and pharynx  29,730  7,320 1.3 0.9 1.9 1.3 T,A
Liver  17,550  15,420 1.7 1.5 1.5 1.4 A
Esophagus  14,520  13,570 1.4 2.0 1.6 1.9 T,A, F
Total  745,810 344,850
Sources: Colditz GA, Samplin-Salgado M, Ryan CT, et al. Harvard Center for Cancer Prevention. 
Harvard report on cancer prevention, volume 5: fulfilling the potential for cancer prevention: policy 
approaches. Cancer Causes Control. 2002;13(3):199–212; American Cancer Society. (ACS) Cancer 
facts & figures for African Americans. Atlanta, GA: ACS, 2005; Schottenfeld D, Beebe-Dimmer JL. 
Advances in cancer epidemiology: understanding causal mechanisms and the evidence for imple-
menting interventions. Annu Rev Public Health. 2005;26:37–60.
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In the last decade, epidemiological, public policy, and economic research has 
demonstrated that practices of industries such as the tobacco, alcohol, and food may 
contribute to behaviors and environments that increase cancer risk.20,21,22,23 During 
this same period, public health professionals, health and consumer advocates, and 
elected officials have worked to modify corporate practices that harm health.20,21,22,23,24 
However, to date there has been little discussion about how corporate practices may 
influence cancer disparities, and there is a paucity of work that has presented public 
officials and public health departments with well-articulated policy options for primary 
prevention of cancer that move beyond individual behavior change. This commentary 
is an attempt to address this gap.
addressing Social Determinants of Health  
in order to Reduce Disparities 
In recent years, health researchers and social epidemiologists have devoted new atten-
tion to the social determinants of health, studying how factors such as income, social 
status, education, employment, occupation, social and physical environments, culture, 
and stigma influence health, and developing various conceptual models to explain these 
relationships.25,26,27 Arguing that individual behavior and genetic influences account 
for only a portion of the burden of ill health, and that medical interventions and 
 individually-targeted health education can have only a modest impact on population 
health, these investigators make the case for modifying social determinants as a strategy 
for primary prevention.28,29 Link and Phelan18 distinguish between fundamental (or 
underlying) and proximate causes of ill health and argue that health interventions that 
fail to address underlying causes of illness merely redistribute the burden of disease, 
often to more vulnerable populations. Modifying fundamental causes has the potential 
to reduce incidence of diseases such as cancer and, by targeting such interventions to 
the most vulnerable, to reduce disparities in health.30
Research on disparities in cancer has identified various social determinants including 
poverty, less formal education, racism, and limited access to health care.7,31,32 Of these, 
disparities in access to and quality of health care have been best studied, showing that 
differences in screening practices, early intervention, and treatment contribute to dispari-
ties in cancer mortality.7,12,33 While this research suggests important priorities for health 
care policy, it does not address primary prevention of cancer. A few researchers have 
noted that differential targeting of lower socioeconomic status (SES) and ethnic/racial 
groups by the tobacco, alcohol, and food industries may contribute to disparities in 
cancer,20,34,35,36 but little systematic research has taken the practices of these industries 
to be a fundamental social determinant of health that could be modified to contribute 
to primary prevention of cancer. In the following section we summarize the available 
literature about practices of tobacco, alcohol, and food industries as determinants of 
cancer risk in an effort to identify both what we know about the influence of corporate 
practices, and gaps in our knowledge that may guide future research.
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Practices of tobacco, alcohol, and Food Industries  
as Determinants of Cancer Risk 
tobacco. Tobacco use is the largest preventable cause of premature death and disease 
in the United States, accounting for an estimated 478,000 deaths per year.37 About 30% 
of U.S. cancer deaths are attributable to active smoking, and tobacco use contributes 
to 16 types of cancer, including lung, colon and rectum, stomach, liver, and others.37 
Cigarette smoking causes more than 85% of lung cancer deaths.37 Broadly speaking, 
without a tobacco industry that aggressively promotes and distributes affordable 
tobacco products, illnesses and deaths from tobacco use would decline precipitously. 
More narrowly, industry practices that have been linked to morbidity and mortality 
include advertising targeted at young people;38,39 product promotions and corporate 
sponsorships;40 political opposition to clean air laws, tobacco excise taxes and publicly 
supported counter-advertising and other legislation;41 misrepresentation or withholding 
of scientific evidence on the health consequences of tobacco use;23 and media campaigns 
emphasizing individual responsibility for tobacco use.42 
alcohol. While hepatocellular cancer (HCC) is relatively rare, it is the most rapidly 
increasing type of cancer in the U.S., in part because of the spread of Hepatitis C virus, 
a predisposing factor.43 Alcohol abuse leads to 32 to 45% of HCC cases in the United 
States.44 In addition, recent research suggests that increasing incidence of diabetes 
mellitus and fatty liver disease may also contribute to HCC incidence,45suggesting a 
possible role for diet as well. Tobacco and alcohol in excess of three drinks per day 
interact to increase the risk of liver, breast, and colorectal cancers.35 It is estimated that 
combined exposure to alcohol and tobacco account for at least 75% of U.S. cancers of 
the oral cavity, pharynx, larynx, and esophagus.36 
Alcohol industry practices associated with excess alcohol consumption include tar-
geting advertising towards young people46 and heavy drinkers, two groups that account 
for half the alcohol consumed in the U.S.; designing and marketing alcohol products 
to appeal to new markets, including young people; sponsoring sports events in order 
to create the norm that sports and alcohol go together;47 making alcohol more avail-
able in low-income and Black and Latino communities,47 and working in the political 
arena to oppose excise taxes, counter-advertising, and other alcohol control measures.22 
These activities are designed to maintain alcohol sales and may therefore contribute to 
incidence of alcohol-related diseases. 
Food. In research from the 1980s and 1990s, McGinnis and Foege48 estimated that 
14% of all deaths were attributable to diet and physical inactivity while, earlier, Doll 
and Peto49estimated that 35% of cancer deaths were attributable to diet alone. More 
recently, researchers have debated the extent to which diet influences either the inci-
dence or progression of cancer.50,51 
An emerging consensus is that the previous approach that focused on the role of 
individual foods or nutrients (e.g., fiber, fat, Vitamin E), as either risk or protective 
factors, may oversimplify the complex role of diet in carcinogenesis. A more useful 
approach might be to look at overall composition and balance of diet and the quan-
tity of overall food intake rather than single components. The emerging evidence that 
31Freudenberg, Galea, and Fahs
obesity is a risk factor for cancer51,52 is cause for alarm, given the rapid rise in global 
obesity rates. 
Several recent studies show a clear relationship between diet and cancer mortal-
ity. For example, Mai et al.53 found that an overall diet in a national sample of U.S. 
women, measured by the Recommended Food Score as having a sum of 23 recom-
mended food items, was inversely associated with overall mortality from cancer, and 
especially breast, colon/rectum, and lung cancers, as well as with incidence of lung 
cancer. Fairly consistent evidence suggests that diets high in fruits and vegetables may 
protect against cancer.17,54 The American Cancer Society cohort study estimated that 
the preventive impact of maintaining a body mass index (BMI) of less than 25 was a 
15–25% reduction of cancer deaths in women and 10–14% in men, a total of 90,000 
cancer deaths per year.55 
Unlike tobacco or alcohol, food is a necessary product for human health, and food 
producers have the potential to promote health. However, the food industry has con-
sistently used product design, advertising, pricing, sponsorship of scientific research, 
lobbying, campaign contributions, and other strategies to influence individual dietary 
behavior in ways that support profitability but not human health.20 Partly as a result, the 
American diet better reflects the food choices promulgated by the food industry than 
the food choices recommended by nutritionists.56 As Nestle57 has observed, the single 
most important nutritional health message for the American people is to eat less, yet 
the food industry has successfully opposed this message and dominates public discourse 
on food with the message to eat more. For example, by supporting professional nutri-
tion organizations to endorse its views, by promoting voluntary rather than mandatory 
guidelines on school food sales and advertising to children, and by emphasizing physical 
inactivity rather than nutrition as the cause of obesity, the food industry has made it 
more difficult to reduce obesity rates.20,57 Recent research linking obesity and overall food 
consumption to various forms of cancer52 suggests that modifying industry practices 
that encourage obesity (in concert with increasing opportunities for physical activity) 
may be a promising strategy for primary prevention of several types of cancer. 
In sum, it is estimated on the basis of epidemiologic studies, that in industrialized 
countries effective interventions to eliminate tobacco smoking and environmental 
tobacco smoke, to moderate alcohol consumption, and to reverse the rising prevalence 
of obesity would result in a 50% reduction in cancer mortality.44 No other medical 
advances promise such potential. 
Industry Practices as Determinant of Disparities 
The above review suggests that the tobacco, alcohol, and food (TAF) industries use 
similar strategies to promote their products, to encourage higher levels of consumption, 
and to resist public efforts to reduce use. Previous work21 and a variety of evidence from 
industry-specific studies suggest that several TAF industry practices warrant further 
investigation for their role in increasing cancer risk. These include advertising,47,58,59 
product availability through retail density,60,61 pricing,62,63 and political opposition to 
public health prevention policies that threaten profitability.20,64,65 Credible (if contested) 
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evidence demonstrates that each of these practices contributes to increased consumption 
of a cancer-causing product and the observed variability of these industry practices by 
population or community, suggesting a possible role in health disparities. Moreover, 
successful public health campaigns to modify these practices suggest the plausibility 
of policy interventions.20,21,66,67 
A few examples illustrate the breadth of this research. Research has demonstrated 
that 
• Tobacco, alcohol, and food companies target advertising at Blacks and at 
lower-income communities, leading to greater exposure to health-damaging 
messages.35,47,68
• Decisions about where to locate retail outlets and the density of such outlets result 
in differential access by socioeconomic status and race/ethnicity to unhealthy 
products such as tobacco, alcohol, and high fat foods and less access to healthy 
products such as fresh fruits and vegetables.61,62 For example, a study in Detroit 
found that the nearest supermarket was, on average, 1.1 miles further away 
from neighborhoods in which African Americans resided than from White 
neighborhoods.69 
• Product promotions and corporate sponsorships often target vulnerable 
groups.40,63
• Existing government regulation (such as restrictions on the sale of single ciga-
rettes, bans on indoor smoking, placement of tobacco and billboard advertising, 
or food safety rules) may be enforced differently in African American and low-
income neighborhoods compared with White and better-off neighborhoods.34,70 
For example, one California study found that underage Black and Latino youth 
were 2.5 times more likely to be sold cigarettes than their White counterparts.34
• Vulnerable populations may have less access to public health campaigns that pro-
vide the knowledge and skills to reduce the impact of health-damaging industry 
practices.68 
These practices contribute to differences by race/ethnicity and class in use of cancer-
causing products.46,71,72 Although a wide body of literature has demonstrated these dif-
ferential exposures to tobacco, alcohol, and food industry practices and linked them to 
higher levels of cancer risk behavior, to date little research has compared the relative 
contribution of different practices across industries, attempted to assess the cumulative 
burden of these practices, or systematically examined the benefits of public policies 
designed to prevent cancer and other diseases by modifying tobacco, alcohol, and food 
industry practices. 
A clear understanding of the mechanisms or pathways by which specific corporate 
practices contribute to cancer disparities and the relative magnitude of the cancer 
burden associated with different practices and industries could help to identify policy 
priorities for primary prevention. When combined with systematic analyses of the 
efficacy of strategies to change corporate practices, such information could provide 
health officials with evidence-based guidance for cancer prevention policies. 
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Strategies to Change Corporate Practices
In recent years, several organizations have mobilized to change the practices of the 
tobacco, food, and alcohol industries. For example, national advocacy organizations 
such as the Center for Science in the Public Interest and the Union of Concerned 
Scientists; professional organizations such as the American Cancer Society and the 
American Diabetes, Heart, and Lung Associations; state and local elected officials and 
health departments; and grassroots coalitions have all worked to force the withdrawal 
of unhealthy new products, to require companies to fund public health campaigns, 
to discourage use of unhealthy products by raising taxes or restricting access, and to 
restrict corporate influence in the political process.73,74,75 These campaigns have operated 
at the national, state, and local levels and used legislative, electoral, legal, media, and 
community organizing strategies.74 While many scientists, journalists, and advocates 
have written about a single campaign or a single industry, only a handful of researchers 
have sought to compare efforts across two or more industries.73,74,76,77 
In some cases, these campaigns have targeted industry practices that contribute 
directly to disparities in cancer. For example, in Philadelphia, a coalition of African 
American, community, church, and health organizations led a campaign to force R.J. 
Reynolds Tobacco Company to drop plans for test marketing Uptown cigarettes, a 
brand aimed at African Americans.79 Similarly, a coalition of Chicago Black and Latino 
groups and the attorneys general of several states worked together to force R.J. Reynolds 
to modify its Kool Mixx, a tobacco promotional campaign that used hip hop music to 
appeal to young Blacks and Latinos.38 Also in Chicago, a neighborhood coalition and 
a university joined forces to advocate bans on alcohol and tobacco billboards in low-
income communities of color.80 Many communities have used land-zoning regulations 
to reduce the density of alcohol, tobacco, and fast food establishments.81 In other cases, 
community or health advocacy organizations have launched counter-advertising cam-
paigns using African American or Latino images and themes designed to counteract 
industry’s use of similar elements. In schools across the country, including many in big 
cities with high proportions of low-income students, parents and advocacy organizations 
are working to force food companies to end marketing of high-calorie low-nutrient 
foods within schools.82 Finally, some low-income neighborhoods have sponsored farm-
ers markets in order to make fresh fruits and vegetables more accessible.83
In sum, public health campaigns to modify TAF industry practices that increase 
cancer risk are a promising strategy for the primary prevention of cancer. By focusing 
attention on this domain of practice, conducting systematic studies of the efficacy of 
various intervention strategies, and better documenting the many existing efforts to 
change industry practices, researchers and health professionals can bring evidence-based 
lessons to policymakers that would assist them in selecting policies to maximize the 
potential for primary prevention of cancer and the reduction or elimination of cancer 
disparities. 
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Conclusion
In this commentary, we have articulated the role that corporate policies and practice 
may play in shaping disparities in cancer morbidity and mortality, highlighted the 
societal costs that may be associated with these corporate practices, and summarized 
some efforts that have been used successfully to influence corporate practices for the 
purposes of improving population health. We conclude with recommendations for 
research, policy, and practice based on these observations. 
First, epidemiologic research about the consequences of corporate practices remains 
in its infancy. Although, to some extent, it is self-evident that within a market-driven 
economy corporate practices will influence consumer behavior and consumer health, 
there are very few empirical studies that have explicitly considered the relation between 
corporate practices and health in such a way as to provide quantitative estimates of the 
role of these practices as health determinants. Public health inquiry about the contribu-
tion of factors at multiple levels of influence has grown tremendously in recent years, 
spurred both by a renewal of interest in the social production of health and disease, 
and by advances in analytic techniques that allow us to examine the contribution of 
factors at multiple levels empirically. However, apart from some research about corpo-
rate practices related to tobacco, limited empirical inquiry has systematically examined 
the role of corporate practices in the cancer outcomes discussed here. We suggest that 
future work seek to quantify the burden of cancer attributable to specified corporate 
practices (e.g., marketing, pricing), much as McGinnis and Foege48 have estimated the 
burden of mortality attributable to individual behavior.
Second, there are several areas in which health policy can be brought to bear on 
the issue of corporate policies producing health, illness, and disparities. Health policy 
practitioners and researchers as well as professional groups such as the American Cancer 
Society must work toward introducing heath into the political discussion about cor-
porate and product regulation. By joining the government-corporate decision-making 
axis, health policy researchers and advocates can contribute to encouraging healthy 
corporate practices and discouraging less healthy ones. Health policy efforts can also 
be directed toward direct engagement in shaping product design and manufacture. 
Historically, the role of public health in influencing corporate practices with respect 
to health has focused more on occupational and environmental than on consumer 
health. By analyzing successes and limitations in protecting workers’ health and the 
environment against corporate harm, it may be possible to learn lessons relevant to 
the primary prevention of cancer and cancer disparities. 
Third, public health practitioners can support policies that promote healthy con-
sumption patterns and combat less healthy ones. For example, public health efforts in 
the past have been successful in limiting advertising to children of clearly unhealthy 
products such as cigarettes or alcohol84,85 but so far have failed to regulate food adver-
tising successfully. These efforts have gone further in some countries than they have 
in the U.S. For example, based on the principle that marketing messages have a duty 
to provide accurate information, Canadian cigarette packaging has long carried stark 
warnings about the deleterious consequences of smoking and images of tobacco-related 
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diseases. These warnings must cover half of the front and back of the package. In addi-
tion to regulating marketing efforts, people in the world of pubic health can be engaged 
in their own efforts to use market forces to counter potentially harmful influences of 
corporate practices. The recent successes of the Truth campaign to limit youth tobacco 
use illustrate the potential for counter-advertising that challenges industry manipula-
tion of vulnerable populations.86
Fourth, public health professionals and researchers can join efforts to re-frame pri-
mary prevention of cancer as an achievable goal that requires policy change. Previous 
research on public health communications suggests that health campaigns that raise 
issues of fairness and justice, that focus on protecting children, and that use existing, 
trusted channels and networks for mobilization are effective in bringing about policy 
change.73,74,87 By applying these lessons to the primary prevention of cancer, health 
professionals can contribute to more effective campaigns for the elimination of cancer 
disparities.
Fifth, health professionals must be persuaded that it is both possible and necessary to 
move beyond secondary prevention of cancer and a narrow focus on improving access 
to cancer screening and counseling. By demonstrating that it is feasible and practical 
to identify and modify the more fundamental determinants of cancer incidence and 
disparities, it may be possible to engage health professionals in the acceleration of 
reductions in the overall and disparate burden of cancer on various populations. 
In sum, substantial evidence shows that practices of the tobacco, alcohol, and food 
industries contribute to cancer incidence and to socioeconomic and racial/ethnic 
disparities in cancer morbidity and mortality. Other evidence suggests that changing 
such corporate practices can reduce consumption of carcinogenic tobacco, alcohol, and 
food products. Making the reduction of tobacco, alcohol, and food corporate practices 
that contribute to cancer a research and policy priority offers significant promise of 
achieving national cancer goals, given high rates of cancer, wide socioeconomic and 
racial/ethnic disparities in certain types of cancer, and limited success to date in pri-
mary prevention of cancer.
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